Atlas Trials

Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma

Clinical trial NCT04448522 · RECRUITING

Trial details

NCT number
NCT04448522
Sponsor
Sun Yat-sen University
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Nasopharyngeal CarcinomaRadiotherapyChemotherapy
Start date
2020-08-18
Primary completion
2026-08-01
Enrollment
508

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.